Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Controlled Trial in HIV-1 Exposed Ugandan Infants to Estimate Additional Benefits (Non-specific Effects) of BCG

NCT02606526 is registered in ClinicalTrials.gov with Makerere University as lead sponsor.

NCT NCT02606526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02606526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Controlled Trial in HIV-1 Exposed Ugandan Infants to Estimate Additional Benefits (Non-specific Effects) of BCG
Lead sponsor
Makerere University
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2016
Completion date
June 21, 2024
Enrollment
4,500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diarrhoea, lower respiratory infection, septicaemia, severe illness